Publications:

1.

Yunqi Xu, Xiaobo Wei, Xu Liu, Jinchi Liao, Jiaping Lin, Peng Zhou, Cansheng
Zhu, Xiaochun Meng, Dongsi Xie, Dongman Chao, Albert J Fenoy, Muhua
Cheng, Beisha Tang,Ying Xia and Qing Wang*. Low Cerebral Glucose
Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and
Parkinsons disease. 2015. Aging and Disease. Acceptance

2.

Long L, Cai XD, Wei XB, Xu YQ, Chen XH, Wang Q* (2015).Progressive
supranuclear palsy: what do we know about it? Current Medicinal Chemistry.
Acceptance. (Impact factor: 3.715).

3.

Wang Q*, Wei X, Gao H, Li J, Liao J, Liu X, Qin B, Yu Y, Deng C, Tang B ,

Huang XF (2014). Simvastatin reverses the downregulation of M1/4 receptor
binding in 6-hydroxydopamine-induced parkinsonian rats: the association with
improvements in long-term memory. Neuroscience. 267, 57-66. (Impact factor:
3.327).

4.

Wang Q*, Li J, Wei X, Liao J, Xu Y, Lu T, Qin B, Xie J, Deng C, Huang X

(2014). Alterations of NMDA receptor binding in various brain regions among
6-hydroxydopamine-induced Parkinsonian rats. Int J Neurosci. 124, 457-465.
(Impact factor:1.528).

5.

Xu YQ, Long L, Yan JQ, Wei L, Pan MQ, Gao HM, Zhou P, Liu M, Zhu CS,
Tang BS, Wang Q*2013.Simvastatin induces neuroprotection in 6-OHDA
lesioned PC12 via the PI3K/AKT/Caspase 3 pathway andanti-inflammatory
responses. CNS Neuroscience & Therapeutics. 19(3):170-7. (Impact factor:
3.784).

6.

Pan M, Gao H, Long L, Xu Y, Liu M, Zou J, Wu A, Wei X, Chen X, Tang B,

Wang Q* (2013). Serum uric acid in patients with Parkinson's disease and
vascular parkinsonism: a cross-sectional study. Neuroimmunomodulation
20,19-28. (Impact factor: 1.779).

7.

Jiang Y, Zou Y, Chen S, Zhu C, Wu A, Liu Y, Ma L, Zhu D, Ma X, Liu M, Kang

Z, Pi R, Peng F, Wang Q, Chen X (2013). The anti-inflammatory effect of

donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Neuropharmacology.73C:415-424. (Impact factor:4.819).
8.

Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q* (2012). Neurotransmitter

receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's
disease. Prog Neurobiol. 97, 1-13. (Impact factor: 10.301).

9.

Zhu C, Xiong Z, Chen X, Peng F, Hu X, Chen Y, Wang Q* (2012). Artemisinin

Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses by
Inhibiting NF-B Pathway in Microglia Cells. PLoS One. 7(4): e35125. (Impact
factor: 3.534).

10. Chen X, Ma L, Jiang Y, Chen S, Zhu C, Liu M, Ma X, Zhu D, Liu Y, Peng F,

Wang Q*, Pi R (2012). Minocycline up-regulates the expression of brain-derived
neurotrophic factor and nerve growth factor in experimental autoimmune
encephalomyelitis. Eur J Pharmacol. 686(1-3):124-9. (Impact factor: 2.684).
11. Wang Q*, Yan J, Chen X, Li J, Yang Y, Weng J, Deng C, Yenari MA (2011).
Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp
Neurol. 230, 27-34.(Impact factor: 4.617).
12. Yan J, Xu Y, Zhu C, Zhang L, Wu A, Yang Y, Xiong Z, Deng C, Huang XF,
Yenari MA, Yang YG, Ying W, Wang Q* 2011 Simvastatin prevents
dopaminergic neurodegeneration in experimental parkinsonian models: the
association with anti-inflammatory responses. PLoS One. 6(6): e20945.(Impact
factor: 3.534).
13. Zhang L, Yan J, Xu Y, Long L, Zhu C, Chen X, Jiang Y, Yang L, Bian L ,
Wang Q* (2011). The combination of homocysteine and C-reactive protein
predicts the outcomes of Chinese patients with Parkinson's disease and vascular
parkinsonism. PLoS One. 6, e19333.(Impact factor: 3.534).
14.

Li H, Zhang M, Chen L, Zhang J, Pei Z, Hu A, Wang Q*(2010). Nonmotor

symptoms are independently associated with impaired health-related quality of
life in Chinese patients with Parkinson's disease. Mov Disord. 25, 2740-2746.
(Impact factor: 5.634).

15. Hu CH, Deng C, Mackovski N, Long L, Zhu C, Yang Y, Wang Y, Chen J, Huang
XF, Wang Q*(2010). Effects of simvastatin and 6-hydroxydopamine on histaminergic H1
receptor binding density in rat brains. Prog Neuropsychopharmacol Biol Psychiatry.

34(8):1419-25. (Impact factor: 4.025).

16. Li Y, Huang XF, Deng C, Meyer B, Wu A, Yu Y, Ying W, Yang GY, Yenari
MA, Wang Q*(2010). Alterations in 5-HT2A receptor binding in various brain
regions among 6-hydroxydopamine-induced Parkinsonian rats. Synapse. 64,
224-230.(Impact factor: 2.428).
17. Li ZR, Jiang ZB, Huang MS, Zhu KS, Wang Q, Shan H (2010). Transvenous
embolization of cavernous sinus dural arteriovenous fistulas using detachable
coils and Glubran 2 acrylic glue via the inferior petrosal sinus approach. Eur
Radiol. 20, 2939-2947. (Impact factor: 4.338).
18. Wang Q*, Zengin A, Deng C, Li Y, Newell KA, Yang GY, Lu Y, Wilder-Smith
EP, Zhao H, Huang XF (2009). High dose of simvastatin induces
hyperlocomotive and anxiolytic-like activities: The association with the
up-regulation of NMDA receptor binding in the rat brain. Exp Neurol. 216,
132-138. (Impact factor: 4.617).
19. Kang K, Huang XF, Wang Q, Deng C (2009). Decreased density of serotonin 2A
receptors in the superior temporal gyrus in schizophrenia-a postmortem study. Prog

Neuropsychopharmacol Biol Psychiatry. 33(5):867-71. (Impact factor: 4.025).

20. Yu Y, Wang Q, Huang XF (2009). Energy-restricted pair-feeding normalizes low
levels of brain-derived neurotrophic factor/tyrosine kinase B mRNA expression
in the hippocampus, but not ventromedial hypothalamic nucleus, in diet-induced
obese mice. Neuroscience. 160, 295-306. (Impact factor: 3.327).
21. Xia W, Wang Z, Wang Q, Han J, Zhao C, Hong Y, Zeng L, Tang L, Ying W
(2009). Roles of NAD(+) / NADH and NADP(+) / NADPH in cell death. Curr
Pharm Des. 15, 12-19. (Impact factor: 3.288).
22. Wang Q, van Hoecke M, Tang X, N Lee H, Zheng Z, Swanson R, A.Yenari M
A.(2009). Pyruvate protects against experimental stroke via an anti-inflammatory
mechanism. Neurobiology of Diseases. 36(1):223-31. (Impact factor: 5.202).

23. Wang Q*, Zengin A, Ying W, Newell KA, Wang P, Yeo W, Wong PT, Yenari
MA, Huang XF(2008). Chronic treatment with simvastatin upregulates
muscarinic M1/4 receptor binding in the rat brain. Neuroscience. 154, 1100-1106.
Cover Page(Impact factor: 3.327).
24. Wang Q*, Huang XF (2008). Effects of chronic treatment of olanzapine and
haloperidol on peptide YY binding densities in the rat brain. Exp Neurol. 209,
261-267. (Impact factor:4.617).
25. Yu Y, South T, Wang Q, Huang XF (2008). Differential expression of
hypothalamic CART mRNA in response to body weight change following
different dietary interventions. Neurochem Int. 52, 1422-1430. (Impact factor:
2.65).
26. Huang XF, Yu Y, Li Y, Tim S, Deng C, Wang Q (2008). Ventromedial
hypothalamic NPY Y2 receptor in the maintenance of body weight in
diet-induced obesity in mice. Neurochem Res. 33, 1881-1888. (Impact factor:
2.551).
27. Wang Q, Tang XN, Yenari MA (2007). The inflammatory response in stroke. J
Neuroimmunol. 184, 53-68. (Impact factor: 2.786).
28. Wang Q*, Aravinda KT, Lim EC, Chan YH, Deng C, Huang XF ,
Wilder-Smith EP (2007). A static handgrip method for distal quantitative sweat
measurements. Neurosci Lett. 421, 229-233. (Impact factor: 2.055).
29. Huang XF, Tan YY, Huang X, Wang Q*(2007). Effect of chronic treatment with
clozapine and haloperidol on 5-HT (2A and 2C) receptor mRNA expression in
the rat brain. Neurosci Res. 59, 314-321. (Impact factor: 2.145).
30. Tang XN, Wang Q, Koike MA, Cheng D, Goris ML, Blankenberg FG, Yenari
MA (2007). Monitoring the protective effects of minocycline treatment with
radiolabeled annexin V in an experimental model of focal cerebral ischemia. J
Nucl Med. 48, 1822-1828. (Impact factor: 5.563).
31. Wei G, Wang D, Lu H, Parmentier S, Wang Q, Panter SS, Frey WN, Ying W
(2007). Intranasal administration of a PARG inhibitor profoundly decreases
ischemic brain injury. Front Biosci. 12, 4986-4996. (Impact factor: 4.249).

32. Ying W, Wei G, Wang D, Wang Q, Tang X, Shi J, Zhang P, Lu H (2007).

Intranasal administration with NAD+ profoundly decreases brain injury in a rat
model of transient focal ischemia. Front Biosci. 12, 2728-2734. (Impact factor:
4.249).
33. Tang XN, Wang Q, Xu LJ, Midori A. Yenari (2007). Blood-brain barrier
disruption is related to NADPH oxidase in experimental stroke. Stroke 38 (2):
555-555. (Impact factor: 6.018).
34. Wang Q*, Tang XN, Wang L, Yenari MA, Ying W, Goh BC, Lee HS,
Wilder-Smith EP, Wong PT (2006). Effects of high dose of simvastatin on levels
of dopamine and its reuptake in prefrontal cortex and striatum among SD rats.
Neurosci Lett. 408(3):189-93. (Impact factor: 2.055).
35. Wang Q, Wee Lee Ting, Hongyuan Yang and Peter T-H Wong (2005). High
doses of simvastatin up-regulate dopamine D1 and D2 receptor expression in the
rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase.
British Journal of Pharmacology 144(7): 933-9. (Impact factor: 5.0).
36. Wang Q, Wang PH, McLachlan C, Wong PT (2005). Simvastatin reverses the
downregulation of dopamine D1 and D2 receptor expression in the prefrontal
cortex of 6-hydroxydopamine-induced Parkinsonian rats. Brain Res. 1045 (1-2),
229-233. (Impact factor: 2.828).
37. Wang Q, Zhu YZ, Steven MC, Ting WL, Yang HY, Wong PTH (2005). The HMG-COA
reductase inhibitor, simvastatin up-regulates the dopamine D1 and D2 receptors
expression in the frontal cortex among 6-hydroxy dopamine- lesioned rat.
Journal of the Neurological Sciences. 87, 229-30. (Impact factor: 2.262).
38. Wang Q, Wong PT (2004). Concurrent up-regulation of eNOS and dopamine D1
and D2 receptor expression in the rat frontal cortex after simvastatin treatment.
Journal of Neurochemistry. 88: 77-77 Suppl. (Impact factor: 4.244).
39.

Farook JM, Wang Q, Moochhala SM, Zhu ZY, Lee L, Wong PT (2004) Distinct
regions of periaqueductal gray (PAG) are involved in freezing behavior hooded
PVG rats on the cat-freezing test apparatus. Neuroscience letters. 354(2),
139-142. (Impact factor: 2.055).

40. Farook JM, Zhu YZ, Wang Q, Moochhala SM, Lee L, Wong PT (2004) Analysis
of strain difference in behavior to Cholecystokinin (CCK) receptor mediated
drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test
apparatus. Neuroscience letters. 358 (3), 215-219. (Impact factor: 2.055).